Research & Development

色久久综合桃花网青娱乐盛宴国产色色影院开盘前瞻:市场担忧情绪复现 恒指或将继续受压下行


色久久综合桃花网 巴爾扎克︰一,《兩個新嫁娘的回憶》;二,《奧諾麗納》(通常與另兩個故事合成一集,即《夏倍上校》與《禁治產》)。青娱乐盛宴国产 一九六○年十月二十一日夜 色色影院

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo